BRAF V600E mutation analysis from may-Grünwald Giemsa-stained cytological samples as an adjunct in identification of high-risk papillary thyroid carcinoma

Endocrine Pathology

Volumn 22, Issue 4, 2011, Pages 195-199

  Patel, Aneeta ^a   Klubo Gwiezdzinska, Joanna ^b   Hoperia, Victoria ^c   Larin, Alexander ^c   Jensen, Kirk ^a   Bauer, Andrew ^a   Vasko, Vasyl ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c Transplantation of Endocrine Organs and Tissues   (Ukraine)

Author keywords

BRAF mutation; FNAB; Thyroid cancer

Indexed keywords

DNA;

ADULT; ARTICLE; ASPIRATION BIOPSY; BRAF GENE; CANCER CLASSIFICATION; CONTROLLED STUDY; CYTOPATHOLOGY; DISEASE ASSOCIATION; DNA EXTRACTION; DNA ISOLATION; DNA SEQUENCE; FEMALE; GIEMSA STAIN; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MUTATIONAL ANALYSIS; MUTATOR GENE; PATIENT ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THYROID FOLLICULAR CARCINOMA; THYROID PAPILLARY CARCINOMA;

BIOPSY, FINE-NEEDLE; CARCINOMA, PAPILLARY, FOLLICULAR; DNA, NEOPLASM; EOSINE YELLOWISH-(YS); GENETIC VARIATION; HUMANS; METHYLENE BLUE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS B-RAF; STAINING AND LABELING; THYROID NEOPLASMS;

EID: 84855273062     PISSN: 10463976     EISSN: 15590097     Source Type: Journal    
DOI: 10.1007/s12022-011-9180-9     Document Type: Article

References (21)

1. B Aschebrook-Kilfoy, et al. 2011 Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006 Thyroid 21 2 125 134 21186939 10.1089/thy.2010.0021
2. GP Yu SP Schantz 2009 Extent of surgery affects papillary thyroid cancer Ann Surg 249 3 549 550 19247059 10.1097/SLA.0b013e31819ac700 author reply 550
3. DM Elaraj C Sturgeon 2009 Adequate surgery for papillary thyroid cancer Surgeon 7 5 286 289 19848062 10.1016/S1479-666X(09)80006-1 1:STN:280: DC%2BD1MjgvFSntg%3D%3D
4. Z Baloch, et al. 2003 Role of repeat fine-needle aspiration biopsy (FNAB) in the management of thyroid nodules Diagn Cytopathol 29 4 203 206 14506672 10.1002/dc.10361 (Pubitemid 37193647)
5. M Sidoti, et al. 2006 The rational use of fine needle aspiration biopsy (FNAB) in diagnosing thyroid nodules Minerva Endocrinol 31 2 159 172 16682939 1:STN:280:DC%2BD283lvVagsA%3D%3D
6. CC Wang, et al. 2010 A large multicenter correlation study of thyroid nodule cytopathology and histopathology Thyroid 21 3 243 251 21190442 10.1089/thy.2010.0243
7. OM Famakinwa, et al. 2010 ATA practice guidelines for the treatment of differentiated thyroid cancer: were they followed in the United States? Am J Surg 199 2 189 198 20113699 10.1016/j.amjsurg.2009.04.022
8. CC Solorzano, et al. 2004 Surgeon-performed ultrasound in the management of thyroid malignancy Am Surg 70 7 576 580 15279178 discussion 580-2
9. JM Stulak, et al. 2006 Value of preoperative ultrasonography in the surgical management of initial and reoperative papillary thyroid cancer Arch Surg 141 5 489 494 16702521 10.1001/archsurg.141.5.489 discussion 494-6 (Pubitemid 43727574)
10. S Leboulleux, et al. 2007 Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer J Clin Endocrinol Metab 92 9 3590 3594 17609301 10.1210/jc.2007-0444 1:CAS:528:DC%2BD2sXhtVGqsrbK (Pubitemid 47435339)
11. M Xing 2007 BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications Endocr Rev 28 7 742 762 17940185 10.1210/er.2007-0007 1:CAS:528:DC%2BD1cXhtVKlsr8%3D (Pubitemid 350294294)
12. V Vasko, et al. 2005 High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes J Clin Endocrinol Metab 90 9 5265 5269 15998781 10.1210/jc.2004-2353 1:CAS:528:DC%2BD2MXhtVWkurrN (Pubitemid 41262284)
13. M Xing, et al. 2005 BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer J Clin Endocrinol Metab 90 12 6373 6379 16174717 10.1210/jc.2005-0987 1:CAS:528:DC%2BD2MXhtlaltL7I (Pubitemid 41759286)
14. M Xing, et al. 2009 BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer J Clin Oncol 27 18 2977 2982 19414674 10.1200/JCO.2008.20.1426 1:CAS:528:DC%2BD1MXoslyis7Y%3D
15. YE Nikiforov, et al. 2009 Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules J Clin Endocrinol Metab 94 6 2092 2098 19318445 10.1210/jc.2009-0247 1:CAS:528:DC%2BD1MXntFGmt7k%3D
16. G Troncone, et al. 2010 Preparation of thyroid FNA material for routine cytology and BRAF testing: a validation study Diagn Cytopathol 38 3 172 176 19693938
17. JA Knauf, et al. 2011 Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFbeta signaling Oncogene 30 28 3153 3162 21383698 10.1038/onc.2011.44 1:CAS:528:DC%2BC3MXivVSms7c%3D
18. YE Nikiforov 2008 Thyroid carcinoma: molecular pathways and therapeutic targets Mod Pathol 21 Suppl 2 S37 S43 18437172 10.1038/modpathol.2008.10 1:CAS:528:DC%2BD1cXltFeiu7k%3D (Pubitemid 351592770)
19. E Kebebew, et al. 2007 The prevalence and prognostic value of BRAF mutation in thyroid cancer Ann Surg 246 3 466 470 17717450 10.1097/SLA. 0b013e318148563d discussion 470-1
20. MN Nikiforova, et al. 2003 BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas J Clin Endocrinol Metab 88 11 5399 5404 14602780 10.1210/jc.2003-030838 1:CAS:528:DC%2BD3sXptVyntrs%3D (Pubitemid 37452745)
21. A Proietti, et al. 2010 BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features Thyroid 20 11 1263 1270 20950194 10.1089/thy.2009.0283